-
Alvameline (Lu 25-109) is a M1
receptor agonist and M2/M3
receptor antagonist that was
under investigation for the
treatment of Alzheimer's disease, but...
-
phase III
clinical trials before being discontinued due to poor results.
Alvameline Milameline Tazomeline Xanomeline Loudon JM,
Bromidge SM,
Brown F, et al...
- 77-LH-28-1 AC-42 AC-260,584
Aceclidine Acetylcholine AF30 AF150(S) AF267B
Alvameline AQRA-741
Arecoline Bethanechol Bevonium Butyrylcholine Carbachol CDD-0034...
- 77-LH-28-1 AC-42 AC-260,584
Aceclidine Acetylcholine AF30 AF150(S) AF267B
Alvameline AQRA-741
Arecoline Bethanechol Bevonium Butyrylcholine Carbachol CDD-0034...
- 77-LH-28-1 AC-42 AC-260,584
Aceclidine Acetylcholine AF30 AF150(S) AF267B
Alvameline AQRA-741
Arecoline Bethanechol Bevonium Butyrylcholine Carbachol CDD-0034...
- 77-LH-28-1 AC-42 AC-260,584
Aceclidine Acetylcholine AF30 AF150(S) AF267B
Alvameline AQRA-741
Arecoline Bethanechol Bevonium Butyrylcholine Carbachol CDD-0034...
- 77-LH-28-1 AC-42 AC-260,584
Aceclidine Acetylcholine AF30 AF150(S) AF267B
Alvameline AQRA-741
Arecoline Bethanechol Bevonium Butyrylcholine Carbachol CDD-0034...
- 77-LH-28-1 AC-42 AC-260,584
Aceclidine Acetylcholine AF30 AF150(S) AF267B
Alvameline AQRA-741
Arecoline Bethanechol Bevonium Butyrylcholine Carbachol CDD-0034...
- 77-LH-28-1 AC-42 AC-260,584
Aceclidine Acetylcholine AF30 AF150(S) AF267B
Alvameline AQRA-741
Arecoline Bethanechol Bevonium Butyrylcholine Carbachol CDD-0034...
- 77-LH-28-1 AC-42 AC-260,584
Aceclidine Acetylcholine AF30 AF150(S) AF267B
Alvameline AQRA-741
Arecoline Bethanechol Bevonium Butyrylcholine Carbachol CDD-0034...
